Bayer AG (BAYRY) Stock Competitors & Peer Comparison
See (BAYRY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BAYRY | $10.56 | -3.47% | 41.5B | -16.48 | -$0.64 | +0.30% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.39% |
| RHHBY | $52.44 | +0.15% | 338.3B | 20.52 | $2.56 | +2.95% |
| RHHBF | $419.69 | -3.46% | 334.1B | 20.54 | $20.43 | +2.96% |
| RHHVF | $411.25 | -2.70% | 327.4B | 20.26 | $20.30 | +3.02% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $144.50 | -1.59% | 275.7B | 20.70 | $6.98 | +3.28% |
| SNYNF | $86.69 | +0.00% | 104.2B | 19.18 | $4.52 | +5.59% |
| GLAXF | $26.00 | +5.80% | 103.7B | 14.13 | $1.84 | +3.45% |
| CHGCY | $24.68 | -0.16% | 81.3B | 29.75 | $0.83 | +3.33% |
Stock Comparison
BAYRY vs BMYMP Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, BAYRY is priced at $10.56, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, BAYRY's ROE is -0.07%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, BAYRY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check BMYMP's competition here
BAYRY vs RHHBY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, RHHBY has a market cap of 338.3B. Regarding current trading prices, BAYRY is priced at $10.56, while RHHBY trades at $52.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas RHHBY's P/E ratio is 20.52. In terms of profitability, BAYRY's ROE is -0.07%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, BAYRY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check RHHBY's competition here
BAYRY vs RHHBF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, RHHBF has a market cap of 334.1B. Regarding current trading prices, BAYRY is priced at $10.56, while RHHBF trades at $419.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas RHHBF's P/E ratio is 20.54. In terms of profitability, BAYRY's ROE is -0.07%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, BAYRY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check RHHBF's competition here
BAYRY vs RHHVF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, RHHVF has a market cap of 327.4B. Regarding current trading prices, BAYRY is priced at $10.56, while RHHVF trades at $411.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas RHHVF's P/E ratio is 20.26. In terms of profitability, BAYRY's ROE is -0.07%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, BAYRY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check RHHVF's competition here
BAYRY vs AZNCF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, BAYRY is priced at $10.56, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, BAYRY's ROE is -0.07%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, BAYRY is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check AZNCF's competition here
BAYRY vs NVSEF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, NVSEF has a market cap of 275.7B. Regarding current trading prices, BAYRY is priced at $10.56, while NVSEF trades at $144.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas NVSEF's P/E ratio is 20.70. In terms of profitability, BAYRY's ROE is -0.07%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, BAYRY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check NVSEF's competition here
BAYRY vs SNYNF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, SNYNF has a market cap of 104.2B. Regarding current trading prices, BAYRY is priced at $10.56, while SNYNF trades at $86.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas SNYNF's P/E ratio is 19.18. In terms of profitability, BAYRY's ROE is -0.07%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, BAYRY is less volatile compared to SNYNF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check SNYNF's competition here
BAYRY vs GLAXF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, GLAXF has a market cap of 103.7B. Regarding current trading prices, BAYRY is priced at $10.56, while GLAXF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas GLAXF's P/E ratio is 14.13. In terms of profitability, BAYRY's ROE is -0.07%, compared to GLAXF's ROE of +0.36%. Regarding short-term risk, BAYRY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GLAXF's competition here
BAYRY vs CHGCY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, CHGCY has a market cap of 81.3B. Regarding current trading prices, BAYRY is priced at $10.56, while CHGCY trades at $24.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas CHGCY's P/E ratio is 29.75. In terms of profitability, BAYRY's ROE is -0.07%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, BAYRY is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check CHGCY's competition here
BAYRY vs CHGCF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, CHGCF has a market cap of 79.5B. Regarding current trading prices, BAYRY is priced at $10.56, while CHGCF trades at $48.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas CHGCF's P/E ratio is 29.09. In terms of profitability, BAYRY's ROE is -0.07%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, BAYRY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check CHGCF's competition here
BAYRY vs OTSKY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, OTSKY has a market cap of 38.6B. Regarding current trading prices, BAYRY is priced at $10.56, while OTSKY trades at $36.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas OTSKY's P/E ratio is 16.85. In terms of profitability, BAYRY's ROE is -0.07%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OTSKY's competition here
BAYRY vs OTSKF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, OTSKF has a market cap of 34B. Regarding current trading prices, BAYRY is priced at $10.56, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas OTSKF's P/E ratio is 14.98. In terms of profitability, BAYRY's ROE is -0.07%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OTSKF's competition here
BAYRY vs DSKYF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, DSKYF has a market cap of 31.2B. Regarding current trading prices, BAYRY is priced at $10.56, while DSKYF trades at $17.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas DSKYF's P/E ratio is 19.47. In terms of profitability, BAYRY's ROE is -0.07%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, BAYRY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check DSKYF's competition here
BAYRY vs DSNKY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, DSNKY has a market cap of 30.6B. Regarding current trading prices, BAYRY is priced at $10.56, while DSNKY trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas DSNKY's P/E ratio is 19.14. In terms of profitability, BAYRY's ROE is -0.07%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, BAYRY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check DSNKY's competition here
BAYRY vs ALPMF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, ALPMF has a market cap of 27.5B. Regarding current trading prices, BAYRY is priced at $10.56, while ALPMF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas ALPMF's P/E ratio is 15.05. In terms of profitability, BAYRY's ROE is -0.07%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, BAYRY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ALPMF's competition here
BAYRY vs ALPMY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, ALPMY has a market cap of 25.4B. Regarding current trading prices, BAYRY is priced at $10.56, while ALPMY trades at $14.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas ALPMY's P/E ratio is 13.90. In terms of profitability, BAYRY's ROE is -0.07%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, BAYRY is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ALPMY's competition here
BAYRY vs ORINY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, ORINY has a market cap of 21.4B. Regarding current trading prices, BAYRY is priced at $10.56, while ORINY trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas ORINY's P/E ratio is 17.35. In terms of profitability, BAYRY's ROE is -0.07%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, BAYRY is less volatile compared to ORINY. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check ORINY's competition here
BAYRY vs GIKLY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, GIKLY has a market cap of 15B. Regarding current trading prices, BAYRY is priced at $10.56, while GIKLY trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas GIKLY's P/E ratio is 16.26. In terms of profitability, BAYRY's ROE is -0.07%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, BAYRY is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check GIKLY's competition here
BAYRY vs RCDTF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, RCDTF has a market cap of 12.2B. Regarding current trading prices, BAYRY is priced at $10.56, while RCDTF trades at $60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas RCDTF's P/E ratio is 22.81. In terms of profitability, BAYRY's ROE is -0.07%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, BAYRY is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check RCDTF's competition here
BAYRY vs CHJTF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, BAYRY is priced at $10.56, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, BAYRY's ROE is -0.07%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, BAYRY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CHJTF's competition here
BAYRY vs ORINF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, BAYRY is priced at $10.56, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas ORINF's P/E ratio is 18.89. In terms of profitability, BAYRY's ROE is -0.07%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, BAYRY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ORINF's competition here
BAYRY vs CSPCY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, CSPCY has a market cap of 10.8B. Regarding current trading prices, BAYRY is priced at $10.56, while CSPCY trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas CSPCY's P/E ratio is 18.75. In terms of profitability, BAYRY's ROE is -0.07%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, BAYRY is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check CSPCY's competition here
BAYRY vs GIFOF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, BAYRY is priced at $10.56, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, BAYRY's ROE is -0.07%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, BAYRY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GIFOF's competition here
BAYRY vs GIFLF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, GIFLF has a market cap of 7.6B. Regarding current trading prices, BAYRY is priced at $10.56, while GIFLF trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas GIFLF's P/E ratio is 15.66. In terms of profitability, BAYRY's ROE is -0.07%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, BAYRY is less volatile compared to GIFLF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check GIFLF's competition here
BAYRY vs KYKOF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, KYKOF has a market cap of 7.6B. Regarding current trading prices, BAYRY is priced at $10.56, while KYKOF trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas KYKOF's P/E ratio is 17.81. In terms of profitability, BAYRY's ROE is -0.07%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, BAYRY is less volatile compared to KYKOF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check KYKOF's competition here
BAYRY vs OPHLY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, OPHLY has a market cap of 7B. Regarding current trading prices, BAYRY is priced at $10.56, while OPHLY trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas OPHLY's P/E ratio is 15.95. In terms of profitability, BAYRY's ROE is -0.07%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, BAYRY is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check OPHLY's competition here
BAYRY vs OPHLF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, BAYRY is priced at $10.56, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas OPHLF's P/E ratio is 15.65. In terms of profitability, BAYRY's ROE is -0.07%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, BAYRY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OPHLF's competition here
BAYRY vs DPHAY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, BAYRY is priced at $10.56, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, BAYRY's ROE is -0.07%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, BAYRY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check DPHAY's competition here
BAYRY vs SNPHY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, SNPHY has a market cap of 3.9B. Regarding current trading prices, BAYRY is priced at $10.56, while SNPHY trades at $12.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas SNPHY's P/E ratio is 16.71. In terms of profitability, BAYRY's ROE is -0.07%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check SNPHY's competition here
BAYRY vs SNPHF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, BAYRY is priced at $10.56, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas SNPHF's P/E ratio is 15.26. In terms of profitability, BAYRY's ROE is -0.07%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, BAYRY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check SNPHF's competition here
BAYRY vs VRBCF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, VRBCF has a market cap of 3.4B. Regarding current trading prices, BAYRY is priced at $10.56, while VRBCF trades at $408.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas VRBCF's P/E ratio is 19.49. In terms of profitability, BAYRY's ROE is -0.07%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, BAYRY is less volatile compared to VRBCF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check VRBCF's competition here
BAYRY vs HAWPY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, BAYRY is priced at $10.56, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas HAWPY's P/E ratio is 14.27. In terms of profitability, BAYRY's ROE is -0.07%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check HAWPY's competition here
BAYRY vs HAWPF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, BAYRY is priced at $10.56, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, BAYRY's ROE is -0.07%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, BAYRY is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check HAWPF's competition here
BAYRY vs PTKFF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, PTKFF has a market cap of 2.2B. Regarding current trading prices, BAYRY is priced at $10.56, while PTKFF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas PTKFF's P/E ratio is N/A. In terms of profitability, BAYRY's ROE is -0.07%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, BAYRY is less volatile compared to PTKFF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check PTKFF's competition here
BAYRY vs LYPHF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, LYPHF has a market cap of 1.3B. Regarding current trading prices, BAYRY is priced at $10.56, while LYPHF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas LYPHF's P/E ratio is 16.39. In terms of profitability, BAYRY's ROE is -0.07%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, BAYRY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check LYPHF's competition here
BAYRY vs TGRNF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, TGRNF has a market cap of 633.9M. Regarding current trading prices, BAYRY is priced at $10.56, while TGRNF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas TGRNF's P/E ratio is 9.90. In terms of profitability, BAYRY's ROE is -0.07%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, BAYRY is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check TGRNF's competition here
BAYRY vs JCRRF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, BAYRY is priced at $10.56, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, BAYRY's ROE is -0.07%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, BAYRY is less volatile compared to JCRRF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check JCRRF's competition here
BAYRY vs MAYNF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, MAYNF has a market cap of 130M. Regarding current trading prices, BAYRY is priced at $10.56, while MAYNF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas MAYNF's P/E ratio is -2.13. In terms of profitability, BAYRY's ROE is -0.07%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, BAYRY is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check MAYNF's competition here
BAYRY vs PTKFY Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, PTKFY has a market cap of 9.8M. Regarding current trading prices, BAYRY is priced at $10.56, while PTKFY trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas PTKFY's P/E ratio is 9.57. In terms of profitability, BAYRY's ROE is -0.07%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, BAYRY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check PTKFY's competition here
BAYRY vs PSYGF Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, BAYRY is priced at $10.56, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, BAYRY's ROE is -0.07%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, BAYRY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check PSYGF's competition here
BAYRY vs CRXTQ Comparison June 2026
BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYRY stands at 41.5B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, BAYRY is priced at $10.56, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYRY currently has a P/E ratio of -16.48, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, BAYRY's ROE is -0.07%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, BAYRY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CRXTQ's competition here